Precision targeting of autoimmune diseases

Autoimmune diseases represent a wide range of disorders affecting specific organs or the entire body, all characterized by the immune system’s misrecognition of self-antigens. These conditions arise from a combination of genetic and environmental factors. The immune system in these disorders fails to properly distinguish between foreign pathogens and the body’s own structures, leading to sustained attacks on healthy cells, tissues and organs. This pathological process results in chronic inflammation, progressive tissue damage, fibrosis and eventual organ dysfunction. To date, researchers have identified around 150 autoimmune diseases, with several validated drug targets in approved therapies.

In this Application note, Sino Biological explore a targeted approach for autoimmune diseases and the leveraging of cancer therapy success for autoimmune treatment.